HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alberto Cremonesi Selected Research

Myocardial Infarction

1/2020Similarities and Differences Between Primary Percutaneous Coronary Intervention and Mechanical Thrombectomy.
9/2017A propensity score matched comparative study between paclitaxel-coated balloon and everolimus-eluting stents for the treatment of small coronary vessels.
3/2017Trends of percutaneous coronary intervention in Italy in the last 10 years.
1/2017Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial.
4/2015A 2-year follow-up of a randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels the BELLO study.
3/2015Quantification of manual thrombus removal in patients with acute coronary syndromes: a study exploiting serial frequency domain-optical coherence tomography.
2/2013Association between proximal stent edge positioning on atherosclerotic plaques containing lipid pools and postprocedural myocardial infarction (from the CLI-POOL Study).
12/2012A randomized multicenter study comparing a paclitaxel drug-eluting balloon with a paclitaxel-eluting stent in small coronary vessels: the BELLO (Balloon Elution and Late Loss Optimization) study.
4/2012Management of combined severe carotid and coronary artery disease.
5/2011Early and long-term outcomes after combined percutaneous revascularization in patients with carotid and coronary artery stenoses.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alberto Cremonesi Research Topics

Disease

14Thrombosis (Thrombus)
11/2020 - 07/2002
13Stroke (Strokes)
12/2023 - 09/2005
12Carotid Stenosis (Carotid Artery Stenosis)
05/2023 - 06/2006
11Myocardial Infarction
01/2020 - 06/2007
10Cardiovascular Diseases (Cardiovascular Disease)
09/2017 - 07/2002
7Carotid Artery Diseases
08/2016 - 08/2003
4Hemorrhage
11/2020 - 07/2012
4Aortic Valve Stenosis (Aortic Stenosis)
06/2019 - 11/2012
4Acute Coronary Syndrome
02/2015 - 05/2012
3Pathologic Constriction (Stenosis)
11/2014 - 06/2006
2ST Elevation Myocardial Infarction
05/2017 - 08/2012
2Prolapse
08/2016 - 05/2011
2Stable Angina
01/2015 - 07/2002
2Atherosclerotic Plaque (Atheroma)
02/2013 - 04/2002
1Intracranial Embolism
08/2022
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
11/2020
1COVID-19
11/2020
1Infections
11/2020
1Ischemic Stroke
01/2020
1Atherosclerosis
02/2018
1Aortic Valve Insufficiency (Aortic Regurgitation)
01/2018
1Coronary Artery Disease (Coronary Atherosclerosis)
09/2017
1Death (Near-Death Experience)
09/2017
1Peripheral Arterial Disease
01/2017
1Inflammation (Inflammations)
01/2017
1Abdominal Aortic Aneurysm
11/2016
1Coronary Occlusion
04/2016
1Chronic Renal Insufficiency
12/2015
1Cardiac Sudden Death (Sudden Cardiac Arrest)
02/2015
1AIDS-Related Complex (ARC)
02/2013
1Coronary Disease (Coronary Heart Disease)
04/2012
1Carotid Artery Thrombosis
11/2005
1Atrial Fibrillation
11/2005
1Ischemia
11/2005
1Embolism (Embolus)
11/2005
1Essential Thrombocythemia
11/2005
1Myocardial Ischemia (Ischemic Heart Diseases)
07/2002
1Unstable Angina
07/2002

Drug/Important Bio-Agent (IBA)

4omega-Chloroacetophenone (Mace)IBA
09/2017 - 12/2012
2CholesterolIBA
03/2015 - 04/2002
2Glycoproteins (Glycoprotein)IBA
05/2014 - 07/2012
2Eptifibatide (Integrilin)FDA Link
05/2014 - 07/2012
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
05/2014 - 07/2012
2Tirofiban (Aggrastat)FDA Link
05/2014 - 07/2012
1C-Reactive ProteinIBA
11/2020
1Interleukin-6 (Interleukin 6)IBA
11/2020
1tocilizumab (atlizumab)FDA Link
11/2020
1Interleukin-6 Receptors (Interleukin 6 Receptor)IBA
11/2020
1Paclitaxel (Taxol)FDA LinkGeneric
09/2017
1N-(2-naphthalene)sulfonyl-DL-tryptophan (A 91)IBA
03/2017
1MicroRNAs (MicroRNA)IBA
01/2017
1LigandsIBA
01/2017
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
01/2017
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2017
1Carbon DioxideIBA
12/2015
1LipidsIBA
02/2013
1MB Form Creatine KinaseIBA
02/2013
1Adenosine (Adenocard)FDA LinkGeneric
05/2012
1nitinolIBA
08/2006
1FibrinIBA
04/2002

Therapy/Procedure

24Stents
12/2023 - 07/2002
12Therapeutics
09/2018 - 12/2008
8Carotid Endarterectomy
11/2022 - 12/2008
7Percutaneous Coronary Intervention
01/2020 - 05/2011
5Embolic Protection Devices
12/2012 - 08/2003
4Transcatheter Aortic Valve Replacement
09/2018 - 11/2012
4Endarterectomy (Thromboendarterectomy)
01/2017 - 11/2005
2Catheters
01/2020 - 11/2005
2Surgical Amputation (Amputations)
10/2017 - 01/2016
1Secondary Prevention
05/2023
1Thrombectomy
01/2020
1Length of Stay
06/2019
1Blood Transfusion (Blood Transfusions)
06/2019
1Surgical Instruments (Clip)
06/2019
1Drug-Eluting Stents
02/2018
1Precision Medicine
01/2017
1Bioprosthesis
04/2016
1Contraindications
12/2015
1Endovascular Procedures
01/2014
1Coronary Artery Bypass (Coronary Artery Bypass Surgery)
04/2012
1Aftercare (After-Treatment)
05/2011